Cargando…

Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study

Melanoma of unknown primary (MUP) may have a different biology to melanoma of known primary, but clinical trials of novel therapies (e.g., immune checkpoint or BRAF/MEK inhibitors) have not reported the outcomes in this population. We therefore evaluated the overall survival (OS) among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verver, D, van der Veldt, AAM, van Akkooi, ACJ, Verhoef, C, Grünhagen, DJ, Louwman, WJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900034/ https://www.ncbi.nlm.nih.gov/pubmed/30801710 http://dx.doi.org/10.1002/ijc.32229

Ejemplares similares

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
por: Verver, Danielle, et al.
Publicado: (2021)

Primary Melanoma Characteristics of Metastatic Disease: A Nationwide Cancer Registry Study
por: Zhou, Catherine, et al.
Publicado: (2021)

Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma
por: Mulder, E.E.A.P., et al.
Publicado: (2020)

Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study
por: Clayton, Bethan, et al.
Publicado: (2022)

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
por: Mulder, E.E.A.P., et al.
Publicado: (2021)

Alcohol consumption, cigarette smoking and cancer of unknown primary risk: Results from the Netherlands Cohort Study
por: Hermans, Karlijn E. P. E., et al.
Publicado: (2020)

False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T‐VEC)
por: Mulder, Evalyn E. A. P., et al.
Publicado: (2021)

Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes
por: Verver, D., et al.
Publicado: (2018)

Mediterranean diet adherence and risk of pancreatic cancer: A pooled analysis of two Dutch cohorts
por: Schulpen, Maya, et al.
Publicado: (2018)

Change in mammographic density across birth cohorts of Dutch breast cancer screening participants
por: Napolitano, George, et al.
Publicado: (2019)

Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
por: Breekveldt, Emilie C. H., et al.
Publicado: (2022)

The unfavorable effects of COVID‐19 on Dutch advanced melanoma care
por: van Not, Olivier J., et al.
Publicado: (2021)

Outcome After Therapeutic Lymph Node Dissection in Patients with Unknown Primary Melanoma Site
por: Prens, Sebastiaan P., et al.
Publicado: (2011)

Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
por: Sangers, Tobias E., et al.
Publicado: (2022)

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs
por: Franken, M.G., et al.
Publicado: (2021)

Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma
por: Potjer, Thomas P, et al.
Publicado: (2021)

The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma
por: Derks, S.H.A.E., et al.
Publicado: (2022)

Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin
por: Verver, D., et al.
Publicado: (2017)

Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population‐based study
por: Schulpen, Maya, et al.
Publicado: (2021)

Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site
por: Gos, Aleksandra, et al.
Publicado: (2014)

Challenges in assessing the sunscreen‐melanoma association
por: Rueegg, Corina S., et al.
Publicado: (2019)

Incidence and mortality trends of melanoma in Croatia, 1988-2008
por: Barbarić, Jelena, et al.
Publicado: (2012)

A case–control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda
por: Mpunga, Tharcisse, et al.
Publicado: (2018)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
por: Khan, Yasir, et al.
Publicado: (2019)

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
por: van der Meer, Daniël J., et al.
Publicado: (2020)

Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018
por: Board, Ruth, et al.
Publicado: (2020)

Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis
por: Rozhnova, Ganna, et al.
Publicado: (2018)

Circulating insulin‐like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
por: Bradbury, Kathryn E., et al.
Publicado: (2018)

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
por: Jochems, Anouk, et al.
Publicado: (2019)

Social participation in older adults with joint pain and comorbidity; testing the measurement properties of the Dutch Keele Assessment of Participation
por: Hermsen, Lotte A H, et al.
Publicado: (2013)

Increased risk of second malignancies after in situ breast carcinoma in a population-based registry
por: Soerjomataram, I, et al.
Publicado: (2006)

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families
por: Potjer, Thomas P., et al.
Publicado: (2019)

Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women
por: Hermens, Marjolein, et al.
Publicado: (2021)

Significant inter‐ and intra‐laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma
por: Mulder, Evalyn E.A.P., et al.
Publicado: (2022)

A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands
por: Boon, Eline, et al.
Publicado: (2018)

Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry
por: van der Willik, Kimberly D., et al.
Publicado: (2019)

The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk
por: Rainey, Linda, et al.
Publicado: (2020)

Inflammation as a validated prognostic determinant in carcinoma of unknown primary site
por: Mohamed, Z, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n3sro2praphvss2qbos71mtd5p